WITHDRAWN: Terazosin for benign prostatic hyperplasia.

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'WITHDRAWN: Terazosin for benign prostatic hyperplasia.'. Together they form a unique fingerprint.

Medicine & Life Sciences